Astex Licenses Lead Candidates to Novartis
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 67 (Table of Contents)
Published: 6 Jan-2006
DOI: 10.3833/pdr.v2006.i67.576 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Astex Therapeutics and Novartis entered into licensing agreement for Astex’s drug candidates AT9311 which is in preclinical development and AT7519 that is in phase 1 clinical trial for treating solid tumors...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS